KDP — Keurig Dr Pepper Inc.

Sentiment is constructive but not euphoric. KDP beat Q2 2026 estimates with adjusted EPS of $0.57 vs. $0.54 consensus and revenue of $7.31B vs. $7.24B, while legacy organic net sales grew 7.3%. Analysts lean Buy (17 Buy / 11 Hold) with recent targets raised to $38 by Morgan Stanley and UBS. The offsetting caution is a 24.7% decline in U.S. Coffee operating income, higher interest expense, and green coffee cost inflation, which keeps the stock from being chased aggressively.

Revenue grew steadily from roughly $3.8B per quarter in 2023 to $4.5B by Q4 2025, consistent with mid-single-digit organic growth. The Q2 2026 reported revenue of $7.31B is a massive step-change from the April JDE Peet's acquisition, not a sudden organic acceleration — legacy organic growth was still 7.3%. The notable negative trend is margin compression: operating margins were consistently in the low-to-mid 20s through 2023-2025, fell to 19.0% in Q1 2026 and 9.2% in Q2 2026, while net income dropped to $142M and EPS to $0.044. That is acquisition integration, higher interest, and coffee cost pressure layered on top of an otherwise healthy beverage business, not evidence of collapsing demand.

On trailing GAAP numbers, KDP looks expensive: as of 2026-08-27 the TTM P/E is 32.1x versus its 5-year average of 25.9x. P/S of 2.16x is below the 5-year average of 3.2x, and the negative PEG of -2.763 is not meaningful given one-off acquisition and impairment noise. Using the next-fiscal-year EPS estimate of $2.292, the forward P/E is roughly 13.9x, which is fair-to-cheap for a defensive beverage staple if those earnings are credible — the market is paying up for trailing earnings but not for the JDE-adjusted forward earnings power.

The pricing tension is clear: the stock is at ~32x trailing EPS of $1.049 but only ~14x analyst forward EPS of $2.292. That is a wide gap caused by the JDE Peet's acquisition and temporary earnings drag. If management delivers on JDE cost synergies, coffee cost relief, and the planned split, the market is currently underpricing the stock. If coffee costs stay high, interest expense keeps rising, or integration stumbles, the trailing multiple offers no cushion and the stock could stay range-bound around $30-32.

As of 2026-08-27, RSI is 55.79, neutral rather than overbought or oversold. Price is 2.98% above the 20-day, 2.32% above the 50-day, and 10.05% above the 200-day moving average. That indicates a moderate uptrend, but the stock is not stretched enough to call overbought. The main timing caution is that it is already ~10% above the 200-day, so buying a pullback toward the 50-day would offer a better risk/reward than chasing at $31.88.

• Elevated green coffee costs — Arabica prices are up roughly 30% since June, directly pressuring U.S. Coffee margins.
• Higher interest rates and post-acquisition leverage — net interest expense was up 88.1% in the first half, with leverage at 4.4x and a target of 4.1x by year-end 2026.
• Tariff and packaging/transport input costs remain a margin headwind, especially for the coffee segment.
• Consumer staples sector rotation — defensive cash-flow businesses are supported when growth leadership is uncertain, but high debt reduces the defensive appeal.
• Upcoming structural split into Beverage Co. and Global Coffee Co. is a major corporate action that will drive sentiment and valuation frameworks.

• Barclays Global Consumer Staples Conference on September 10, 2026 — management can give fresh color on JDE integration, 2H coffee costs, and split timing.
• Q3 2026 earnings in late October/early November 2026 — should show whether green coffee cost pressure is moderating as management suggested.
• Planned structural separation into Beverage Co. and Global Coffee Co. in early 2027, which analysts see as a value-unlocking event.
• Continued momentum in Dr Pepper Zero Sugar, GHOST, C4, and other energy partnerships.
• Deleveraging progress toward 4.1x by year-end 2026 and eventual synergy realization from JDE Peet's.

• Green coffee cost inflation persists longer than expected, keeping U.S. Coffee margins under pressure.
• Integration and synergy execution for the ~$17.4B JDE Peet's acquisition could disappoint.
• Elevated leverage and rising interest expense — net interest for the first half rose 88.1% and the current ratio is only 0.479.
• Execution, tax, and regulatory risk around the planned 2027 split.
• Trailing GAAP valuation is rich at 32x, leaving limited downside protection if forward earnings estimates are cut.

KDP is a reasonable long-term buy for an investor willing to tolerate integration and commodity-cost noise. The core beverage portfolio is growing, analyst estimates point to much higher JDE-adjusted earnings power, and the 2027 split is a genuine catalyst; the stock at $31.88 is not pricing in full success. The main caveat is that this is not a low-risk balance sheet story right now, so position sizing should respect the leverage and coffee-cost swings.

Calculated by applying a 16.2x forward P/E multiple to the next-fiscal-year EPS estimate of $2.292. The 16.2x multiple is KDP's 5-year average P/E of 25.9x discounted by roughly 37% to reflect higher leverage, coffee-cost cyclicality, and JDE integration risk, while still acknowledging the improved earnings base and split catalyst.